Bone marrow micrometastases and gastrointestinal cancer detection and significance

American Journal of Gastroenterology

Volumn 95, Issue 7, 2000, Pages 1644-1651

  Maguire, Donal ^a   O'Sullivan, Gerald C ^a   Collins, J Kevin ^a   Morgan, John ^a   Shanahan, Fergus ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN;

BONE MARROW METASTASIS; CANCER DIAGNOSIS; CANCER STAGING; CARCINOMA CELL; CELL CYCLE S PHASE; CELL PROLIFERATION; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM CANCER; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; REVIEW;

BONE MARROW NEOPLASMS; CELL SURVIVAL; GASTROINTESTINAL NEOPLASMS; HUMANS; NEOPLASM METASTASIS; PATHOLOGY; PREVALENCE; PROGNOSIS;

EID: 0033930258     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00991-6     Document Type: Review

References (74)

1. Hart I.R., Saini A. Biology of tumour metastases. Lancet. 339:1992;1453-1457.
2. Liotta L.A., Stetler-Stevensen W.G. Tumour invasion and metastases An imbalance of positive and negative regulation . Cancer Res. 51:(suppl):1991;5054-5059.
3. Liotta L.A., Stegg P.S., Stetler-Stevensen W.G. Cancer metastases and angiogenesis An imbalance of positive and negative regulation . Cell. 64:1991;327-336.
4. O'Brien M.G., Fitzgerald E.F., Lee G., et al. A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. Am J Gastroenterol. 90:1995;2191-2194.
5. Posner M.R., Mayer R.J. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am. 8:1994;533-553.
6. Pandha H.S., Waxman J. Tumour markers. Q J Med. 88:1995;233-241.
7. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 264:1991;1444-1450.
8. O'Sullivan G., Collins J.K., Kelly J., et al. Micrometastases Marker of metastatic potential or evidence of residual disease . Gut. 40:1997;512-515.
9. Hart I.R., Goode N.T., Wilson R.E. Molecular aspects of the metastatic cascade. Biochem Biophys Acta. 989:1989;65-84.
10. Duffy M.J. Cancer metastasis Biological and clinical aspects . Ir J Med Sci. 167:1998;4-8.
11. Jiang W.G., Hallett M.B., Puntis M.C.A. Motility factors in cancer invasion and metastasis. Surg Res Commun. 16:1994;219-237.
12. Matrisian L.M. The atrix-degrading metalloproteinases. Bio Essays. 14:1992;455-463.
13. Albelda S.M. Role of integrins and other cell adhesion molecules in tumour progression and metastases. Lab Invest. 68:1993;4-17.
14. Hynes R.O. Integrins Versatility, modulation and signalling in cell adhesion . Cell. 69:1992;11-25.
15. Banks R.E., Gearing A.J., Hemmingway I.K., et al. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer. 68:1993;122-124.
16. Gearing A.J., Hemingway I., Pigott R., et al. Soluble forms of vascular adhesion molecules E-selection, ICAM-1, and VCAM-1 Pathological significance . Ann NY Acad Sci. 667:1992;324-331.
17. Fidler I.J., Hart I.R. Biological diversity in metastatic neoplasms Origins and implications . Science. 217:1982;998-1003.
18. 125I-2-deoxyuridine . J Natl Cancer Inst. 45:1970;773-782.
19. Schlimok G., Funke I., Holzmann B., et al. Micrometastatic cancer cells in bone marrow In vitro detection with anti-cytokeratin and in vivo labelling with anti-17-1-A monoclonal antibodies . Proc Natl Acad Sci USA. 84:1987;8672-8676.
20. Gatter K.C., Alcock C., Heryet A., et al. Clinical importance of analysing malignant tumours of uncertain origin with immunohistochemical techniques. Lancet. 1:1985;1302-1305.
21. Mansi J.L., Berger U., Easton D. Micrometastases in bone marrow patients with primary breast cancer Evaluation as an early predictor of bone metastases . Br Med J. 295:1987;1093-1096.
22. Schlimok G., Riethmuller G. Detection, characterization and tumorgenicity of disseminated tumor cells in human bone marrow. Sem Cancer Biol. 1:1990;207-215.
23. O'Sullivan G.C., Collins J.K., O'Brien F., et al. Micrometastases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer. Gastroenterology. 109:1995;1535-1540.
24. Schlmok G., Funke I., Holzmann B., et al. Micrometastatic cancer cells in bone marrow In vitro detection with anti-cytokeratin and in vivo labelling with anti-17-1A monoclonal antibodies . Proc Natl Acad Sci USA. 84:1987;8672-8676.
25. Lindemann F., Schlimok G., Dirschedel P., et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet. 340:1992;685-689.
26. O'Sullivan G.C., Clarke A., Stuart R., et al. Micrometastases in esophagogastric cancer High detection rate in resected rib segments . Gastroenterology. 116:1999;543-548.
27. Pantel K., Aignherr C., Kollermann J., et al. Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer. Eur J Cancer. 31A:1995;1627-1632.
28. Tsuchiya A., Sugano K., Klmijima I., et al. Immunohistochemical evaluation of lymph node micrometastases from breast cancer. Acta Oncol. 35:1996;425-428.
29. Harbeck N., Untch M., Pache L., et al. Tumour cell detection in bone marrow of breast cancer patients at primary therapy Results of a 3-year median follow-up . Br J Cancer. 69:1994;566-571.
30. Basu D., Singh T., Shinghal R.N. Micrometastases in bone marrow in breast cancer. Indian J Pathol Microbiol. 37:1994;159-164.
31. Neumaier M., Gerhard M., Wagener C. Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene. 159:1995;43-47.
32. Gerhard M., Juhl H., Kalthoff H., et al. Specific detection of carcinoembryonic antigen expressing tumour cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol. 12:1994;725-729.
33. Moll R., Franke W.W., Schiller D.L., et al. The catalog of human cytokeratins Pattern of expression in normal epithelia, tumours and cultured cells . Cell. 31:1982;11-24.
34. Fuchs E. Keratins as biochemical markers of epithelial differentiation. Trends Genet. 4:1988;277-281.
35. Badder B.L., Frank W.W. Cell type-specific and efficient synthesis of human cytokeratin 19 in transgenic mice. Differentiation. 45:1990;109-118.
36. Stasiak P.C., Lane E.B. Sequence of cDNA coding for human cytokeratin 19. Nucleic Acids Res. 15:1987;10058.
37. Stasiak P.C., Purkis P.E., Leigh I.M., et al. Keratin 19 Predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins . J Invest Dermatol. 92:1989;707-716.
38. Schlimok G., Funke I., Pantel K., et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer Methodological aspects of detection and prognostic significance . Eur J Cancer. 27:1991;1461-1465.
39. Knapp A.C., Franke W.W. Spontaneous losses of control of cytokeratin gene expression in transformed non-epithelial human cells occurring at different levels of regulation. Cell. 59:1989;67-69.
40. Jarvinen M., Andersson L., Virtanen I. K562 erythroleukamia cells express cytokeratins 8, 18 and 19 and epithelial membrane antigen that dissapear after induced differentiation. J Cell Physiol. 143:1990;310-320.
41. Pantel K., Schlimok G., Angstwurm M., et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumour cells in bone marrow. J Haematotherapy. 3:1994;165-173.
42. Neumaier M., Gerhard M., Wagener C. Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene. 159:1995;43-47.
43. Gerhard M., Juhl H., Kalthoff H., et al. Specific detection of carcinoembryonic antigen expressiong tumour cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol. 12:1994;725-729.
44. Hussain M., Kurkuraga M., Biggar S., et al. Prostate cancer Flow cytometric methods for detection of bone marrow micrometastases . Cytometry. 26:1996;40-46.
45. Traweek S.T., Liu J., Battifora H. Keratin gene expression in non-epithelial tissues. Am J Pathol. 142:1993;1111-1118.
46. Burchill S.A., Bradbury M.F., Pitman K., et al. Detection of epithelial cancers in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 71:1995;278-281.
47. Chelly J., Concordet J.P., Kaplan J.C., et al. Illegitimate transcription Transcription of any gene in any cell type . Proc Natl Acad Sci USA. 86:1989;2617-2621.
48. Hochtlen-Vollamar W., Gruber R., Bodenmuller H., et al. Occult epithelial tumour cells detected by an enzyme immunoassay specific for cytokeratin 19. Int J Cancer. 70:1997;396-400.
49. Little V.R., Lockett S.J., Pallavicini M.G. Genotype/phenotype analyses of low frequency tumour cells using computerized image microscopy. Cytometry. 23:1996;344-357.
50. Muller P., Weckermann D., Reithmüller G., et al. Detection of genetic alteration in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet Cytogenet. 88:1996;8-16.
51. Pallavicini M.G., Cher M.L., Bowers E.E., et al. Chromosomal aneusomies in prostate cancer micrometastasis. Proc Am Acad Cancer Res. 36:1995;69.
52. Riesenberg R., Oberneder R., Kriegmair M., et al. Immunocytochemical double staining of cytokeratin and prostate specific antigen individual prostatic tumour cells. Histochemistry. 99:1993;61-66.
53. Gallee M.P., Van Der Korput H.A., Van Der Kwast T.H., et al. Characterization of monoclonal antibodies raised against prostatic cell line PC-82. Prostate. 9:1986;33-45.
54. Braun S., Pantel K. Biological characteristics of micrometastatic carcinoma cells in bone marrow. Curr Top Microbiol Immunol. 213:1996;163-177.
55. Pantel K., Dickmanns A., Zippelius A., et al. Establishment of micrometastatic carcinoma cell lines A novel source of tumour cell vaccines . J Natl Cancer Inst. 87:1995;1162-1168.
56. Pantel K., Schlimok G., Braun S., et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst. 85:1993;1419-1424.
57. Braun S., Pantel K. Biological characteristics of micrometastatic carcinoma cells in bone marrow. Curr Top Microbiol Immunol. 213:1996;163-177.
58. Shpall E.J., Stemmer S.M., Bearman S.I., et al. New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation. Breast Cancer Res Treat. 26:(suppl):1993;519-527.
59. Ross A.A., Miller G.W., Moss T.J., et al. Immunocytochemical detection of tumour cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer. Bone Marrow Transplant. 15:1995;923-929.
60. Riethmüller G., Johnson J.P. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancer. Curr Opin Immunol. 4:1992;647-655.
61. O'Sullivan G.C., Corbett A.R., Shanahan F., et al. Regional immunosuppression in esophageal squamous cancer Evidence from functional studies with matched lymph nodes . J Immunol. 157:1996;4717-4720.
62. O'Connell J., O'Sullivan G.C., Collins J.K., et al. The Fas counter attack Fas-mediated T cell killing by colon cancer cells expressing Fas ligand . J Exp Med. 184:1996;1075-1082.
63. Bennett M.W., O'Connell J., O'Sullivan G.C., et al. The Fas counterattack in vivo Apoptotic depletion of tumor-infiltrating lymphocytes (TIL) associated with Fas ligand (FasL) expression by human esophageal carcinoma . J Immunol. 1600:1998;5669-5675.
64. Passlick B., Izbicki J.R., Simmel S., et al. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 expression on operable non-small cell lung carcinomas. Eur J Cancer. 30:1995;376-381.
65. Pantel K., Schlimok G., Kutter D., et al. Frequent down regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res. 51:1991;4712-4715.
66. Cote R.J., Beattie E.J., Chaiwun B., et al. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg. 222:1995;415-423.
67. Ross A.A., Miller G.W., Moss T.J., et al. Immunocytochemical detection of tumour cells in bone marrow and peripheral blood stem cells collections from patients with ovarian cancer. Bone Marrow Transplant. 15:1995;929-933.
68. Pantel K., Aighnerr C., Kollermann J., et al. Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer. Eur J Cancer. 31A:1995;1627-1632.
69. Cote R.J., Rosen P.P., Lesser M.L., et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol. 9:1991;1749-1756.
70. Pantel K., Izbicki J.R., Angstwurm M., et al. Immunocytoclogical detection of bone marrow micrometastases in operable non-small cell lung cancer. Cancer Res. 53:1993;1027-1031.
71. Diel I.J., Kaufmann M., Costa S.D., et al. Micrometastatic breast cancer cells in bone marrow at primary surgery Prognostic value in comparison with nodal status . J Natl Cancer Inst. 88:1996;1652-1658.
72. Riethmüller G., Schneider-Gadicke E., Schmiegel W., et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Duke's C colorectal carcinoma. Lancet. 343:1994;1177-1186.
73. Schlimok G., Pantel K., Loibner H., et al. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody Towards a novel surrogate test to monitor adjuvant therapies of solid tumours . Br J Cancer. 31A:1995;1799-1803.
74. Thorban S., Roder J.D., Nekarda H., et al. Disseminated epithelial tumour cells in bone marrow of patients with esophageal cancer Detection and prognostic significance . World J Surg. 20:1996;567-572.